Cargando…

CK2—An Emerging Target for Neurological and Psychiatric Disorders

Protein kinase CK2 has received a surge of attention in recent years due to the evidence of its overexpression in a variety of solid tumors and multiple myelomas as well as its participation in cell survival pathways. CK2 is also upregulated in the most prevalent and aggressive cancer of brain tissu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castello, Julia, Ragnauth, Andre, Friedman, Eitan, Rebholz, Heike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374411/ https://www.ncbi.nlm.nih.gov/pubmed/28067771 http://dx.doi.org/10.3390/ph10010007

Ejemplares similares

Alterations of Expression of the Serotonin 5-HT4 Receptor in Brain Disorders
por: Rebholz, Heike, et al.
Publicado: (2018)

Publisher Correction: The Dopamine D5 receptor contributes to activation of cholinergic interneurons during L-DOPA induced dyskinesia
por: Castello, Julia, et al.
Publicado: (2020)

The Dopamine D5 receptor contributes to activation of cholinergic interneurons during L-DOPA induced dyskinesia
por: Castello, Julia, et al.
Publicado: (2020)

Comparing Two Neurodevelopmental Disorders Linked to CK2: Okur-Chung Neurodevelopmental Syndrome and Poirier-Bienvenu Neurodevelopmental Syndrome—Two Sides of the Same Coin?
por: Ballardin, Demetra, et al.
Publicado: (2022)

CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders
por: Baier, Andrea, et al.
Publicado: (2022)

Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
por: Spinello, Zaira, et al.
Publicado: (2021)

Involvement of Intestinal Enteroendocrine Cells in Neurological and Psychiatric Disorders
por: Yu, Liangen, et al.
Publicado: (2022)

Are neurological and psychiatric disorders different?()
por: David, Anthony S., et al.
Publicado: (2015)

The Multiple Personalities of the Regulatory Subunit of Protein Kinase CK2: CK2 Dependent and CK2 Independent Roles Reveal a Secret Identity for CK2β
por: Bibby, Ashley C., et al.
Publicado: (2005)

Therapeutic targeting of CK2 in acute and chronic leukemias
por: Buontempo, F, et al.
Publicado: (2018)

Targeting protein kinase CK2 in the treatment of cholangiocarcinoma
por: Jayaraman, Padma-Sheela, et al.
Publicado: (2021)

Complement in neurological disorders and emerging complement-targeted therapeutics
por: Dalakas, Marinos C., et al.
Publicado: (2020)

Quantitative Evaluation of the Use of Actigraphy for Neurological and Psychiatric Disorders
por: Pan, Weidong, et al.
Publicado: (2014)

Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders
por: Werremeyer, Amy, et al.
Publicado: (2020)

The Effects of Statins on Neurotransmission and Their Neuroprotective Role in Neurological and Psychiatric Disorders
por: Kosowski, Michał, et al.
Publicado: (2021)

Proline Metabolism in Neurological and Psychiatric Disorders
por: Yao, Yuxiao, et al.
Publicado: (2022)

CK2 and the Hallmarks of Cancer
por: Firnau, May-Britt, et al.
Publicado: (2022)

Hepatitis C virus infection, and neurological and psychiatric disorders – A review
por: Yarlott, Lydia, et al.
Publicado: (2017)

Association of dry eye disease with psychiatric or neurological disorders in elderly patients
por: Han, Sang Beom, et al.
Publicado: (2017)

De novo mutations in neurological and psychiatric disorders: effects, diagnosis and prevention
por: Gauthier, Julie, et al.
Publicado: (2012)

Current perspectives on deep brain stimulation for severe neurological and psychiatric disorders
por: Kocabicak, Ersoy, et al.
Publicado: (2015)

Repurposing Peroxisome Proliferator-Activated Receptor Agonists in Neurological and Psychiatric Disorders
por: Sagheddu, Claudia, et al.
Publicado: (2021)

CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target
por: Chua, Melissa M.J., et al.
Publicado: (2017)

Editorial: Neurological and Psychiatric Disorders in Endocrine Diseases
por: Tamagno, Gianluca, et al.
Publicado: (2015)

Neuroimaging distinction between neurological and psychiatric disorders()
por: Crossley, Nicolas A., et al.
Publicado: (2015)

5-HIAA as a Potential Biological Marker for Neurological and Psychiatric Disorders
por: Jayamohananan, Hridya, et al.
Publicado: (2019)

Psychiatric Aspects of Neurologic Disease
por: Pincus, Jonathan H.
Publicado: (1977)

Effect of Caffeine Consumption on the Risk for Neurological and Psychiatric Disorders: Sex Differences in Human
por: Jee, Hye Jin, et al.
Publicado: (2020)

CK2 Regulation: Perspectives in 2021
por: Roffey, Scott E., et al.
Publicado: (2021)

RP1 Is a Phosphorylation Target of CK2 and Is Involved in Cell Adhesion
por: Stenner, Frank, et al.
Publicado: (2013)

Protein Kinase CK2, a Potential Therapeutic Target in Carcinoma Management
por: Lian, Haiwei, et al.
Publicado: (2019)

Protein Kinase CK2—A Putative Target for the Therapy of Diabetes Mellitus?
por: Ampofo, Emmanuel, et al.
Publicado: (2019)

The role of nitric oxide in brain disorders: Autism spectrum disorder and other psychiatric, neurological, and neurodegenerative disorders
por: Tripathi, Manish Kumar, et al.
Publicado: (2020)

Internet-Based Interventions for Carers of Individuals With Psychiatric Disorders, Neurological Disorders, or Brain Injuries: Systematic Review
por: Spencer, Lucy, et al.
Publicado: (2019)

Targeting Casein Kinase 1 (CK1) in Hematological Cancers
por: Janovská, Pavlína, et al.
Publicado: (2020)

Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders
por: Estrada, José Antonio, et al.
Publicado: (2020)

Drosophila Protein Kinase CK2: Genetics, Regulatory Complexity and Emerging Roles during Development
por: Bandyopadhyay, Mohna, et al.
Publicado: (2016)

Chronic traumatic encephalopathy—a blueprint for the bridge between neurological and psychiatric disorders
por: Albayram, Onder, et al.
Publicado: (2020)

Hypotheses on Mechanisms Linking Cardiovascular and Psychiatric/Neurological Disorders
por: Manev, Hari
Publicado: (2009)

Corrigendum: “Editorial: Neurological and Psychiatric Disorders in Endocrine Diseases”
por: Tamagno, Gianluca, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a7jt59p3ppuh80co7l2n4s9lss